Hubei Jumpcan Pharmaceutical Co., Ltd. Fundamental Rankings

This page is comprehensive fundamental data for Hubei Jumpcan Pharmaceutical Co., Ltd.. Fundamentals are ordered by how Hubei Jumpcan Pharmaceutical Co., Ltd. ranks compared to other companies (ordered high to low). All money values are in CNY. All data is powered by Quandl.

Cite in Wikipedia:

Indicator Value n/price Rank Date Historic
Selling expenses1,032,686,3140.056412015-06-30historic
Other non-current liabilities900,0005.0E-51552015-06-30historic
Proceeds from sell of investment505,000,0000.027382262015-06-30historic
Goodwill192,877,1250.010462512015-06-30historic
Cash paid for dividends, profits or interests313,897,5660.017022642015-06-30historic
Net income329,521,3430.017872662015-06-30historic
Total comprehensive income329,521,3430.017872882015-06-30historic
Operating profit358,280,1890.019432932015-06-30historic
Cash paid for taxes332,526,9210.018032952015-06-30historic
Total profit383,905,8900.020822952015-06-30historic
Other payables489,464,1020.026543312015-06-30historic
Payroll payable79,031,4630.004294032015-06-30historic
Purchases of fixed assets and others226,901,0950.01234402015-06-30historic
Interest receivable57,1670.04522015-06-30historic
Other current assets195,949,0460.010624572015-06-30historic
Cash paid for other financing activities1,100,0006.0E-56622015-06-30historic
Cash inflows from operating activities2,048,673,2230.111096892015-06-30historic
Revenue1,872,717,3050.101547172015-06-30historic
Total cost of goods sold1,522,770,6780.082577522015-06-30historic
Disposal of fixed assets and others116,2001.0E-57542015-06-30historic
Cash outflows from operating activities1,719,676,5910.093257632015-06-30historic
Comprehensive income attributable to minority shareholders-1,678,977-9.0E-58172015-06-30historic
Notes receivable20,975,6470.001148242015-06-30historic
Minority interests gain-1,678,977-9.0E-58312015-06-30historic
Minority interest35,659,3990.001938332015-06-30historic
Fixed assets930,535,0030.050468352015-06-30historic
Net cash flows from investing activities-323,426,680-0.017548572015-06-30historic
Intangible assets177,283,8430.009618742015-06-30historic
Short term borrowings150,000,0000.008139202015-06-30historic
Capital reserve987,683,5920.053569322015-06-30historic
Cash inflows from financing activities310,000,0000.016819572015-06-30historic
Total non-current assets1,747,209,6580.094749642015-06-30historic
Deferred tax assets13,957,1047.6E-410112015-06-30historic
Accounts payable215,277,3860.0116710282015-06-30historic
Financial expenses-2,363,024-1.3E-410382015-06-30historic
Non-operating loss412,3812.0E-510482015-06-30historic
Total liabilities1,094,471,4730.0593510842015-06-30historic
Net change in cash-439,427,614-0.0238311152015-06-30historic
Net cashflow from financing activities-444,997,566-0.0241311722015-06-30historic
Total liabilities and equity3,442,743,8600.1866811802015-06-30historic
Inventories140,289,5090.0076111882015-06-30historic
Prepayment11,878,9266.4E-412462015-06-30historic
Net cash and cash equivalents ending balance204,804,5930.0111112502015-06-30historic
Other receivables5,127,9082.8E-412822015-06-30historic
Diluted eps00.012882015-06-30historic